LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about EvolveImmune Therapeutics…

EvolveImmune Therapeutics Tech Stack

EvolveImmune Therapeutics uses 8 technology products and services including WP Rocket, Fastly, MySQL, and more. Explore EvolveImmune Therapeutics's tech stack below.

  • WP Rocket
    Caching
  • Fastly
    Content Delivery Network
  • MySQL
    Database
  • oEmbed
    Dev Tools
  • Google Fonts API
    Font Scripts
  • Lightbox
    Javascript Libraries
  • Swiper
    Javascript Libraries
  • GraphPad Prism
    Visualisation Software

Media & News

EvolveImmune Therapeutics's Email Address Formats

EvolveImmune Therapeutics uses at least 1 format(s):
EvolveImmune Therapeutics Email FormatsExamplePercentage
First.Last@evolveimmune.comJohn.Doe@evolveimmune.com
94%
Last@evolveimmune.comDoe@evolveimmune.com
3%
LFirst@evolveimmune.comDJohn@evolveimmune.com
1%
First_Last@evolveimmune.comJohn_Doe@evolveimmune.com
2%

Frequently Asked Questions

Where is EvolveImmune Therapeutics's headquarters located?

Minus sign iconPlus sign iconEvolveImmune Therapeutics's main headquarters is located at Branford, CT US. The company has employees across 2 continents, including North AmericaEurope.

What is EvolveImmune Therapeutics's official website and social media links?

Minus sign iconPlus sign iconEvolveImmune Therapeutics's official website is evolveimmune.com and has social profiles on LinkedInCrunchbase.

What is EvolveImmune Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign iconEvolveImmune Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does EvolveImmune Therapeutics have currently?

Minus sign iconPlus sign iconAs of October 2025, EvolveImmune Therapeutics has approximately 57 employees across 2 continents, including North AmericaEurope. Key team members include Chief Financial Officer: J. G.Chief Business Officer: M. F.Vice President Program And Alliance Management: C. C.. Explore EvolveImmune Therapeutics's employee directory with LeadIQ.

What industry does EvolveImmune Therapeutics belong to?

Minus sign iconPlus sign iconEvolveImmune Therapeutics operates in the Biotechnology Research industry.

What technology does EvolveImmune Therapeutics use?

Minus sign iconPlus sign iconEvolveImmune Therapeutics's tech stack includes WP RocketFastlyMySQLoEmbedGoogle Fonts APILightboxSwiperGraphPad Prism.

What is EvolveImmune Therapeutics's email format?

Minus sign iconPlus sign iconEvolveImmune Therapeutics's email format typically follows the pattern of First.Last@evolveimmune.com. Find more EvolveImmune Therapeutics email formats with LeadIQ.

How much funding has EvolveImmune Therapeutics raised to date?

Minus sign iconPlus sign icon As of October 2025, EvolveImmune Therapeutics has raised $20M in funding. The last funding round occurred on Oct 29, 2024 for $20M.

When was EvolveImmune Therapeutics founded?

Minus sign iconPlus sign iconEvolveImmune Therapeutics was founded in 2020.

EvolveImmune Therapeutics

Biotechnology ResearchConnecticut, United States51-200 Employees

EvolveImmune is pioneering a pipeline of unique trispecific T cell engagers with integrated CD2 costimulation. The EVOLVE platform tackles the treatment challenges of cancer cell resistance to current immunotherapies. The company’s lead internal drug candidate, EVOLVE104, will enter the clinic in 2025.

We are based in Branford, CT.

Section iconCompany Overview

Headquarters
Branford, CT US
Website
evolveimmune.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $20M

    EvolveImmune Therapeutics has raised a total of $20M of funding over 3 rounds. Their latest funding round was raised on Oct 29, 2024 in the amount of $20M.

  • $25M$50M

    EvolveImmune Therapeutics's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $20M

    EvolveImmune Therapeutics has raised a total of $20M of funding over 3 rounds. Their latest funding round was raised on Oct 29, 2024 in the amount of $20M.

  • $25M$50M

    EvolveImmune Therapeutics's revenue is estimated to be in the range of $25M$50M

Company Leadership

  • Stylized image of a person
    J. G.
    Chief Financial Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. F.
    Chief Business Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    C. C.
    Vice President Program And Alliance Management
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. M.
    Vice President Of Research And Development
    Phone icon
    Mobile Phone
  • Stylized image of a person
    C. F.
    Co-Founder
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    J. G.
    Founder, Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. A.
    Senior Vice President Cmc And Manufacturing Operations
    Phone icon
    Mobile Phone
  • Stylized image of a person
    C. C.
    Vice President Program And Alliance Management
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. M.
    Vice President Of Research And Development
    Phone icon
    Mobile Phone
  • Stylized image of a person
    T. F.
    Svp, Clinical Development
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.